Newleos secures $93.5m for neuropsychiatric treatments
Newleos has closed an oversubscribed Series A financing round, raising $93.5m to revolutionise neuropsychiatric disorder treatments.
Newleos has closed an oversubscribed Series A financing round, raising $93.5m to revolutionise neuropsychiatric disorder treatments.
What's Your Reaction?
